Ro 106-9920

• Description :

  Ro 106-9920 is a potent inhibitor of NF-kappaB. Ro 106-9920 has the potential for the research of tumor and cancer diseases[1].

• UNSPSC :

  12352005

• Target :

  NF-κB

• Type :

  Peptides

• Related Pathways :

  NF-κB

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/ro-106-9920.html

• Purity :

  99.0

• Solubility :

  DMSO : 20 mg/mL (ultrasonic)

• Smiles :

  O=S(C1=CC=CC=C1)C2=NN3N=NN=C3C=C2

• Molecular Formula :

  C10H7N5OS

• Molecular Weight :

  245.26

• References & Citations :

  [1]Malaver E, et al. NF-kappaB inhibitors impair platelet activation responses. J Thromb Haemost. 2009;7 (8) :1333-1343.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [62645-28-7]